Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sourav Taru Saha

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The FEBS Journal|July 28, 2019
Targeting cellular cholesterol for anticancer therapyLiang Gu, Sourav Taru Saha, Jodie Thomas, et al.
ACS Omega|July 20, 2018
Azide-Alkyne Cycloaddition En Route to 1<i>H</i>-1,2,3-Triazole-Tethered Isatin-Ferrocene, Ferrocenylmethoxy-Isatin, and Isatin-Ferrocenylchalcone Conjugates: Synthesis and Antiproliferative EvaluationAmandeep Singh, Sourav Taru Saha, Shanen Perumal, et al.
Cancers|June 22, 2023
2-Hydroxypropyl-β-cyclodextrin (HPβCD) as a Potential Therapeutic Agent for Breast CancerSourav Taru Saha, Naaziyah Abdulla, Tawanda Zininga, et al.
RSC Advances|May 2, 2022
Synthesis and <i>in vitro</i> anti-proliferative evaluation of naphthalimide-chalcone/pyrazoline conjugates as potential SERMs with computational validationShalini, Pankaj, Sourav Taru Saha, et al.
Investigational New Drugs|November 9, 2019
Anticancer activities of vitamin K3 analoguesKevin W Wellington, Vincent Hlatshwayo, Natasha I Kolesnikova, et al.
ACS Omega|November 23, 2020
Design, Synthesis, Antiproliferative Evaluation, and Molecular Docking Studies of <i>N</i>-(3-Hydroxyindole)-Appended β-Carbolines/Tetrahydro-β-Carbolines Targeting Triple-Negative and Non-Triple-Negative Breast CancerBharvi Sharma, Sourav Taru Saha, Shanen Perumal, et al.
Bioorganic & Medicinal Chemistry|October 27, 2018
Synthesis, computational studies and antiproliferative activities of coumarin-tagged 1,3,4-oxadiazole conjugates against MDA-MB-231 and MCF-7 human breast cancer cellsSanjeev Dhawan, Nagaraju Kerru, Paul Awolade, et al.
RSC Advances|May 6, 2022
Diastereoselective approach to rationally design tetrahydro-β-carboline-isatin conjugates as potential SERMs against breast cancerBharvi Sharma, Amandeep Singh, Liang Gu, et al.
ACS Omega|October 16, 2018
1<i>H</i>-1,2,3-Triazole Tethered Nitroimidazole-Isatin Conjugates: Synthesis, Docking, and Anti-Proliferative Evaluation against Breast CancerSumit Kumar, Sourav Taru Saha, Liang Gu, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The FEBS Journal|July 28, 2019
Targeting cellular cholesterol for anticancer therapyLiang Gu, Sourav Taru Saha, Jodie Thomas, et al.
ACS Omega|July 20, 2018
Azide-Alkyne Cycloaddition En Route to 1<i>H</i>-1,2,3-Triazole-Tethered Isatin-Ferrocene, Ferrocenylmethoxy-Isatin, and Isatin-Ferrocenylchalcone Conjugates: Synthesis and Antiproliferative EvaluationAmandeep Singh, Sourav Taru Saha, Shanen Perumal, et al.
Cancers|June 22, 2023
2-Hydroxypropyl-β-cyclodextrin (HPβCD) as a Potential Therapeutic Agent for Breast CancerSourav Taru Saha, Naaziyah Abdulla, Tawanda Zininga, et al.
RSC Advances|May 2, 2022
Synthesis and <i>in vitro</i> anti-proliferative evaluation of naphthalimide-chalcone/pyrazoline conjugates as potential SERMs with computational validationShalini, Pankaj, Sourav Taru Saha, et al.
Investigational New Drugs|November 9, 2019
Anticancer activities of vitamin K3 analoguesKevin W Wellington, Vincent Hlatshwayo, Natasha I Kolesnikova, et al.
ACS Omega|November 23, 2020
Design, Synthesis, Antiproliferative Evaluation, and Molecular Docking Studies of <i>N</i>-(3-Hydroxyindole)-Appended β-Carbolines/Tetrahydro-β-Carbolines Targeting Triple-Negative and Non-Triple-Negative Breast CancerBharvi Sharma, Sourav Taru Saha, Shanen Perumal, et al.
Bioorganic & Medicinal Chemistry|October 27, 2018
Synthesis, computational studies and antiproliferative activities of coumarin-tagged 1,3,4-oxadiazole conjugates against MDA-MB-231 and MCF-7 human breast cancer cellsSanjeev Dhawan, Nagaraju Kerru, Paul Awolade, et al.
RSC Advances|May 6, 2022
Diastereoselective approach to rationally design tetrahydro-β-carboline-isatin conjugates as potential SERMs against breast cancerBharvi Sharma, Amandeep Singh, Liang Gu, et al.
ACS Omega|October 16, 2018
1<i>H</i>-1,2,3-Triazole Tethered Nitroimidazole-Isatin Conjugates: Synthesis, Docking, and Anti-Proliferative Evaluation against Breast CancerSumit Kumar, Sourav Taru Saha, Liang Gu, et al.
Pageof 1